NIS 300 million for medical startups

Israel’s Peregrine Ventures has established a consortium of leading companies that will jointly develop and invest over NIS 300 million in startups and graduates of Peregrine’s technology incubator. They include Bristol-Myers Squibb, Elbit, and Tel Aviv & Ben Gurion Universities.

This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *